Retroviral intasome assembly and inhibition of DNA strand transfer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within the CIC, the IN dimers are bridged via the exchange of associated NTDs and are joined by a pair of CTDs (referred to as the synaptic CTDs), which act as rigid spacers.”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the intasomes from the prototype foamy virus (PFV, a simiispumavirus) as well as the δ-retroviruses HTLV-1 and simian T-cell lymphotropic virus (STLV) contain four IN subunits (arranged as a dimer-of-dimers)25,29,37,38”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [25]
Experimental — accuracy not yet measured
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Use of TLS parameters to model anisotropic displacements in macromolecular refinement
Winn, M. D., Isupov, M. N., & Murshudov, G. N. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900014736 · Cited by 1,696
Gouet, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg556 · Cited by 1,509
Research works printed but not linked: 2
- Grobler, J. A., Stillmock, K., Miller, M. D. & Hazuda, D. J. Mechanism by which the HIV integrase active-site mutation N155H confers resistance to raltegravir. Antivir. Ther. 13 (suppl. 3). A41 (2008)
- Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography no. 26, (1992)
Cited by
Items 601–700 of 719
Elvitegravir: Novel Quinolone HIV‐1 Integrase Strand Transfer Inhibitor
Shinkai, H., Sato, M., & Matsuzaki, Y. (2011) · Wiley eBooks · doi:10.1002/9781118015377.ch15
Jun, J., Liu, C., Wang, Y., Li, M., Xin, C., & Jie, X. (2011) · InTech eBooks · doi:10.5772/22555
“But, the complete structure of the Primate foamy virus (PFV) IN complexed with the substrate DNA and IN inhibitors raltegravir or elvitegravir has recently been obtained (Hare et al., 2010).”
BackgroundReconsidering the Model of Trim5α Assembly: The Role of the Linker2 (l2) Region in Trim5α Assembly
Johnsen, L. (2014) · Loyola eCommons (Loyola University of Chicago)
Ealy, J. B., Sudol, M., Krzeminski, J., Amin, S., & Katzman, M. (2012) · Virology · doi:10.1016/j.virol.2012.07.022 · Cited by 1
“In this regard, the recent crystallization of full-length prototype foamy virus integrase in complexes with DNA and inhibitors (Hare et al., 2010a; Hare et al., 2010b; Maertens et al., 2010) has been helpful for modeling HIV-1 integrase (Krishnan et al., 2010), but much still needs to be learned…”
BackgroundRetroviral Intasomes: Progress and Questions
Li, M., & Craigie, R. (2012) · Structure · doi:10.1016/j.str.2012.10.004
Christ, F. (2010) · HIV Therapy · doi:10.2217/hiv.10.21
Integrating the HIV-1 assembly/maturation pathway
Potempa, M., & Swanstrom, R. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306620110
Dissection of HIV-1 Env-specific B cell responses in non-human primates
Sundling, C. (2010) · Figshare
SURVEY AND SUMMARY Molecular mechanisms of retroviral integration site selection
Kvaratskhelia, M., Sharma, A., Larue, R. C., Serrao, E., & Engelman, A. (2014)
Self-citationRasila, T. S. (2013) · Helda - University of Helsinki Institutional Repository
Microbiologia, G. E. (2012)
Bolzani, V. D. S., & Fraga, C. A. M. (2010)
Hiv Integrase Mechanisms Of Resistance To Raltegravir, Elvitegravir, And Dolutegravir
Ross, K. T. (2015) · Human Biology
Development of an HIV-1 integrase enzyme strand transfer assay
Qasim, M. (2011) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Viral and host factors affecting efficient revere transcription of HIV-1 genome
Masuda, T. (2011) · Uirusu · doi:10.2222/jsv.61.73
Bioinformatics studies on drug resistance against anti-HIV-1 drugs
Ode, H. (2011) · Uirusu · doi:10.2222/jsv.61.35
Pickford, C., Chaltin, P., Westby, M., Debyser, Z., Desimmie, B. A., Marchand, A., Frauke, C., Shaw, S. M., & Demeulemeester, J. (2012)
Stevenson, M. (2010) · PubMed
Application of molecular dynamics simulations in the study of protein-ligand interactions
Duan, R. (2016) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/67890
“To examine drug resistance via molecular dynamics simulations, it is necessary to have the structure of complexes of HIV-1 integrase binding with INSTIs.”
InfluentialSolution NMR studies of HIV-1 reverse transcriptase
Sharaf, N. G. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Pimentel, V. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2017.tde-15052017-154549
Foamy virus vector integration and application in gene therapy
Sweeney, N. P. (2015) · Spiral (Imperial College London) · doi:10.25560/50704
Cellular Cofactors of HIV as Drug Targets
Desimmie, B. A., Christ, F., & Debyser, Z. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_83
“Despite the recent release of the crystal structure of full-length IN of the prototype foamy virus (PFV) (Hare et al. 2010), there is no crystal structure of full-length HIV-1 IN.”
BackgroundCabrera, A., Huerta, L., Chávez, D., & Medina‐Franco, J. L. (2018) · Computational Molecular Bioscience · doi:10.4236/cmb.2018.83007
“Table 1 summarizes the information of the two structures of RT [14] and one for IN [15] used in this work.”
MethodInfluentialZhang, X., Niu, W., Tang, T., Hou, C., Guo, Y., & Kong, R. (2019) · Chemical Research in Chinese Universities · doi:10.1007/s40242-019-9183-5
Ceresola, E. R. (2019) · IrInSubria (University of Insubria)
An improved lentivirus vector for safer transgene integration and protein transduction
Schenkwein, D. (2013) · UEF eRepo (University of Eastern Finland)
Zhang, D., & Duan, R. (2021) · Chemical Physics Letters · doi:10.1016/j.cplett.2021.138751
Utemiljön ur ett ekosystemtjänstperspektiv
Falck, M. (2015)
DNA Strand Breaks and Gaps Target Retroviral Binding and IntegrationPreprint
Senavirathne, G., Gardner, A., London, J., Fishel, R. A., & Yoder, K. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.17.469012
The KT Jeang Retrovirology prize 2021: Peter Cherepanov
Editorial, R. (2021) · Retrovirology · doi:10.1186/s12977-021-00573-1
“The structure was validated using very clever compatible pairs of mutations designed by Steve Hare and virology experiments in the Engelman lab.”
BackgroundInfluentialDUMMY TITLE FOR ALIASING ARTICLE 215 to ARTICLE 235
Chen, Q., Wei, D., Xu, Q., & Cheng, X. (2014) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-013-0215-4
Dalal, Y. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736601607.793566199
Barkova, A., Adhya, I., Conesa, C., Asif-Laidin, A., Bonnet, A., Rabut, E., Chagneau, C., Lesage, P., & Acker, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1853998/v1
Cellular Cofactors of HIV as Drug Targets
Desimmie, B. A., Christ, F., & Debyser, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_83-1
Molecular determinants for Rous sarcoma virus intasome assembliesPreprint
Bera, S., Shi, K., Aihara, H., Grandgenett, D. P., & Pandey, K. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.02.528060
Carta, F., & Sechi, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00006-1
Sun, Q., Biswas, A., Lyumkis, D., Levy, R., & Deng, N. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.29.569269
Karimi, N., Beirami, A. D., Vahabpour, R., Hajimahdi, Z., & Zarghi, A. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100208
The first HIV-1 integrase inhibitor, raltegravir
Wang, X., Wei, X., & Shen, H. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27402-2.00009-7
Min, S., Kim, S. H., Underwood, M., Wynne, B., & Spreen, W. (2025) · Wiley eBooks · doi:10.1002/9783527845088.ch03
Delineation of a novel assembly intermediate in retroviral integration pathwayPreprint
Chadda, R., Bera, S., Ghoneim, M., Melo, T. D., Grandgenett, D. P., Antony, E., & Pandey, K. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675266
Retroviral intasome architecture shapes the dynamics of target DNA search and integration
Baltierra‐Jasso, L. E., Larue, R. C., Jones, N. D., Tan, Y. Y., Messer, R. K., Ballandras-Colas, A., Engelman, A., Fishel, R. A., & Yoder, K. E. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014070
“Several other retroviral intasome structures have been visualized in recent years revealing a spectrum of IN multimers [9,10,12–14, 16 , Here we characterized the activity of octameric MMTV intasomes under a variety of biochemical conditions.”
InfluentialSelf-citationDelineation of a novel assembly intermediate in Rous sarcoma virus integration pathway
Chadda, R., Bera, S., Ghoneim, M., Melo, T. D., Grandgenett, D. P., Antony, E., & Pandey, K. K. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag270
“Intasomes are composed of IN multimers ranging from four subunits for prototype foamy virus [ 14 ], human T-cell leukemia virus [ 15 ], and simian T-lymphotropic virus type 1 [ 16 ] to 8 for alpha-retrovirus RSV [ 17 , 18 ] and beta-retrovirus mouse mammary tumor virus [ 19 , 20 ].”
Analyse des réponses cellulaires induites par l’intégration d’un ADN étranger au sein du génome
Gay, V. (2010) · theses.fr (ABES) · doi:10.70675/7c4ae339z19ddz46b4zbd54zc859435d8459
Novel potent antiviral molecules targeting the nucleocapsid protein of the HIV-1 virus
Basta, B. (2012) · theses.fr (ABES) · doi:10.70675/151cc823z1197z4e3azbfd9z27dadc35fe11
HIV-1 Integrase During the Time: History of Drugs and Effort for the New Inhibitors’ Identification
Esposito, F., Saccoliti, F., Patacchini, E., & Santo, R. D. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_180
Caractérisation des fonctions cellulaires du facteur de restriction viral APOBEC3A
Niocel, M. (2017) · theses.fr (ABES) · doi:10.70675/b688234az5bc7z4100zb26ez7528ceb4c3ae
KAP1 : un nouveau facteur répresseur de la transcription du VIH-1
Aït-Ammar, A. (2018) · theses.fr (ABES) · doi:10.70675/bef49303zbb98z444bzb86azf445aa0a34db
Optimisation de la stratégie de thérapie génique par vecteur lentiviral pour la β-thalassémie
Giorgi, M. (2019) · theses.fr (ABES) · doi:10.70675/041f272dz23faz452bzb352z46cf95acb76d
Pharmacocinétique du raltégravir pendant la grossesse, par approche de population
Zheng, Y. (2019) · theses.fr (ABES) · doi:10.70675/847acce4zb313z457fz85d2z468f79ac8014
Identification de facteurs cellulaires régulant la rétrotransposition de Ty1 chez S. cerevisiae
Barkova, A. (2019) · theses.fr (ABES) · doi:10.70675/d3dce78az48e8z4209zb2afzd31c32c110b1
Identification of specific phylogenetic properties of HIV-1 M and O integrases
Toccafondi, E. (2022) · theses.fr (ABES) · doi:10.70675/2facab6ezc20az472dz8350z9fb6e718e1d4 · Cited by 1
Darazi, P. E. (2021) · theses.fr (ABES) · doi:10.70675/7bb07492ze915z4ca3z845fzba3bb62a3520 · Cited by 1
Guillon, E. (2023) · theses.fr (ABES) · doi:10.70675/ee27c419z91a5z454eza4f1z0a2e2e0450d5
Molecular basis of the interaction between HIV-1 integrase and viral RNA
Rocchi, C. (2022) · theses.fr (ABES) · doi:10.70675/56a488fez1f79z4d34z81d9z905314a2ca30
HTLV-1 intasome recruits the PP2A-B56 holoenzyme and restricts its phosphatase activityPreprint
Minnell, J. J., Punch, E. K., Vanzo, T., Safari, R., Cronin, N., Cherepanov, P., & Maertens, G. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.722153
Self-citationTemporal Evolution of Drug Resistance to HIV Integrase Inhibitors
Choudhuri, I., Olvera, J. G., Biswas, A., Haldane, A., Levy, R. M., & Lyumkis, D. (2026) · Viruses · doi:10.3390/v18050540 · Cited by 2
“All INSTIs share a core structural motif with a planar arrangement of heteroatoms that chelate two Mg 2+ ions at the IN catalytic site [6,10,12].”
InfluentialAcetylation-mediated regulation of ALV viral proteins: Implications for retroviral inhibition
Cui, N., Han, X., Huang, Q., Wang, P., Wang, L., Xu, C., & Su, S. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014229
Protein‐Protein Interaction as an Efficient Target to Inhibit HIV‐1 Integrase
Zarghi, A., & Hajimahdi, Z. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70221
“However, Hare et al. successfully determined the structure of full‐length integrase from the prototype foamy virus (PFV) in complex with its substrate DNA, two Mg 2+ ions, and various HIV‐1 INSTIs [19, 20].”
Chrencik, J., Su, H.-P., Gómez-Llorente, Y., Palte, R. L., Klein, D. J., Hayes, R. P., Antine, S. P., Asmar-Rovira, G. A., Bertoletti, N., Byrne, N. J., et al. (2026) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798326004390
Non-integrase mechanisms for dolutegravir resistance
Engelman, A. (2026) · Retrovirology · doi:10.1186/s12977-026-00678-5 · Cited by 1
“2B-C) [64–67].”
Self-citationDrug-drug interactions in patients living with HIV and major depression
Antwi, I., & Cory, T. J. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2704520
“By chelating essential Mg 2+ ions at the active site, INSTIs prevent insertion of viral DNA into the host genome, thereby halting productive infection [17,27].”
Dave, P. A., Maheta, J. B., Lakhnotra, D. K., Shaikh, N. H., Ram, I. M., Somaiya, C. P., Parangi, T. F., & Bhola, Y. O. (2026) · Organic & Biomolecular Chemistry · doi:10.1039/d6ob00939e
Saccoliti, F., Patacchini, E., Cara, E., Zarbo, L., Messore, A., Albano, A., Ruggieri, G., Madia, V. N., Scipione, L., Costi, R., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.70428 · Cited by 1
“While early studies on intasomes relied on related retroviruses (such as prototype foamy virus, PFV) [24 – 27] and homology modeling for HIV-1 [28, 29], advances in cryo-EM have ultimately enabled the determination of high-resolution structures [22].”
BindingDB Entry 50004583: Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
BindingDB (2020) · UC San Diego · doi:10.7270/q2bc42cs
BindingDB (2013) · UC San Diego · doi:10.7270/q2xw4kvq
BindingDB Entry 50004628: Discovery of small molecule HIV-1 integrase dimerization inhibitors.
BindingDB (2020) · UC San Diego · doi:10.7270/q2ht2s6h
BindingDB (2024) · UC San Diego · doi:10.7270/q2s75mqx
BindingDB Entry 50044589: Pyridopyrimidinone inhibitors of HIV-1 RNase H.
BindingDB (2015) · UC San Diego · doi:10.7270/q2mg7r34
BindingDB (2020) · UC San Diego · doi:10.7270/q2sn0ctm
BindingDB Entry 50006022: Inhibiting the HIV integration process: past, present, and the future.
BindingDB (2020) · UC San Diego · doi:10.7270/q2qc06gp
Metadata
- Authors
- Hare, S., Gupta, S. S., Valkov, E., Engelman, A., & Cherepanov, P.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Cherepanov, Peter
- Venue
- Nature
- Published
- 2010-01-31
- Volume
- 464
- Issue
- 7286
- Pages
- 232-236
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2837123
- OpenAlex
- W2025344323
- Cited by
- 678
- References
- 50
- Citations by year
- 2026: 14 · 2025: 10 · 2024: 15 · 2023: 21 · 2022: 19 · 2021: 31 · 2020: 29 · 2019: 38 · 2018: 33 · 2017: 31 · 2016: 43 · 2015: 53 · 2014: 49 · 2013: 68 · 2012: 79
- FWCI
- 60.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Diamond Light Source
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (R01AI070042, P30AI060354)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- retroviral integrase, intasome, DNA strand transfer, HIV-1 integrase, integrase strand transfer inhibitors, raltegravir, elvitegravir, antiretroviral drug development, viral DNA integration, protein-DNA interactions
- MeSH terms
- DNA, Viral, Models, Molecular, Retroviridae, HIV-1, Protein Structure, Tertiary, Integrases, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.